ABSTRACT
INTRODUCTION

50
On December 31, 2019, an outbreak of coronavirus causing infections in Wuhan, China, was officially 51 reported. The outbreak rapidly spread to several provinces of China and other countries. Currently, the 52 ongoing outbreak in China caused by a new coronavirus, named 2019-nCoV by WHO, is becoming a 53 global crisis. Notably, the 2019-nCoV is highly similar to the severe acute respiratory syndrome 54 coronavirus (SARS-CoV), which is characterized by high mortality and infectivity. Therefore,
55
information on SARS-CoV will be valuable for the prevention and control of the current outbreak.
56
SARS was first confirmed in Guangdong, China in [2002] [2003] , and subsequently became a pandemic, 57 spreading rapidly to 31 countries and regions, causing panic and a global public health crisis. 1 
62
frontline healthcare workers, including physicians, nurses, and other healthcare workers, who were 63 exposed to the virus while treating and caring for SARS patients in the early stages of the outbreaks,
64
were mainly affected. During the later stages of the outbreak, although precautions to prevent the 65 infection were enhanced, infection of healthcare workers still occurred. 6, 7 No natural SARS-CoV
66
infections have been identified since the last confirmed case in May 2004. 8 The reasons why SARS 67 caused a transient epidemic and was experienced as an isolated event, remain unelucidated. 9 There are
68
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In our current study, we conducted a 13-year follow-up study on a cohort of SARS-CoV-infected 87 healthcare workers for analyzing the presence and persistence of antibodies against SARS-CoV.
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METHODS
89
STUDY SITE AND PARTICIPANT ENROLLMENT
90
The study site was a teaching hospital and the main center for treating clustered SARS cases in 
100
The sera used in this study is derived sample of the annual physical examination of the SARS-CoV 
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111
respectively, for failing to arrange a physical examination or due to resignation. In addition, serum 112 samples from another 20 subjects, from the 95 SARS cases, were collected in 2015 (Table S3) .
113
Another 40 non-SARS infected healthcare workers from the same hospital were enrolled and serum 114 samples were collected, as the control group, to verify the end result data of the 34
115
SARS-CoV-infected healthcare cohort in 2015 (Table S4) . 
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STATISTICAL ANALYSIS
127
Boxplots and heatmaps were used to show the temporal trends and variations in the antibody levels.
128
Non-linear exponential decay models were used to estimate the average decay rates of the antibody 
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DIFFERENCES IN ANTI-SARS-CoV IgG TITERS OF DIFFERENT
169
SARS-CoV-INFECTED GROUPS
170
To analyze the general IgG distributions, subjects were divided into 2 groups: group 1 (n=46),
171
including SARS-CoV-infected healthcare workers enrolled in the original cohort (n=26) and 172 an additional group of SARS-CoV-infected healthcare workers who were enrolled in 2015
173
(n=20), and group 2 (n=40) of non-infected healthcare worker, selected as the control. The
174
IgG against whole virus was above the cutoff value, and the IgG titers were significantly 175 higher in group 1 than in group 2 (p < 0.001; Figure 3A) . A similar trend was observed for
176
IgG against N199 titers, as group 1 had significantly higher IgG titers than group 2 (p=0.034; (Table S5) .
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THE EFFECT OF CORTICOSTEROID TREATMENT ON IgG ANTIBODY
188
RESPONSES
189
During the outbreak, some SARS-CoV-infected healthcare workers received corticosteroid 
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223
IgG antibodies using SARS-CoV whole virus as capture antigens, which has been suggested 224 in previous studies to correlate with neutralizing activity 16 . Moreover, the SARS-CoV N199
225
antigen was used to detect its specific antibody, which has been demonstrated to be specific in
226
clinical diagnosis and SARS-CoV reservoir screening. 21 We therefore adopted the testing of
227
IgG against N199, combined with the titer analysis of IgG against the whole virus, to 228 comprehensively evaluate the SARS antibody duration.
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235
In our cohort, we found that two healthcare workers might have been misdiagnosed with 236 SARS, as the IgG antibodies against both the whole virus and N199 antigen was persistently 237 lower than the cutoff value, for these two patients. Notably, all the cases enrolled in this study . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
